Developing new drugs for diabetes and cardiometabolic disorders: a changing paradigm

Drugs. 2012 Sep 10;72(13):1709-11. doi: 10.2165/11635550-000000000-00000.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / metabolism*
  • Cardiovascular Diseases / prevention & control
  • Clinical Trials as Topic
  • Consumer Product Safety
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / metabolism
  • Drug Discovery*
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use

Substances

  • Hypoglycemic Agents